Rowasa (Meda Pharmaceuticals)
Welcome to the PulseAid listing for the Rowasa drug offered from Meda Pharmaceuticals. This Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals |
NON-PROPRIETARY NAME: | mesalamine |
SUBSTANCE NAME: | MESALAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |
ROUTE: | RECTAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-03-29 |
END MARKETING DATE: | 0000-00-00 |
Rowasa HUMAN PRESCRIPTION DRUG Details:
Item Description | Rowasa from Meda Pharmaceuticals |
LABELER NAME: | Meda Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(g/60mL) |
START MARKETING DATE: | 2016-03-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0037-0066_25b355a1-136b-42d5-bc09-214387ac6784 |
PRODUCT NDC: | 0037-0066 |
APPLICATION NUMBER: | NDA019618 |
Other MESALAMINE Pharmaceutical Manufacturers / Labelers: